Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WMB vs MRNA✓SelectedUSD · MRNAWMB vs MRNA performance historyLatest closeAs of-0.50%11/13
Stock and ETF performance explorer

WMB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+331.4%
MRNA return
+915.3%
Excess return
-583.9%
Maximum drawdown
-66.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.5%-3.4%+2.9%-0.5%
7D+7.8%-12.1%+19.9%+7.8%
30D-5.1%-1.3%-3.8%-5.1%
3M-4.7%+250.9%-255.7%-3.9%
6M-7.4%+343.0%-350.4%-6.8%
YTD+17.5%+657.4%-640.0%+17.6%
1Y+19.5%+794.9%-775.4%+19.4%
3Y+121.3%+218.1%-96.9%+121.8%
5Y+200.5%-3.4%+203.9%+200.2%
All+331.4%+915.3%-583.9%+365.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling